BlackRock Health Sciences Term Trust Common Shares of Beneficial Interest (BMEZ)

FairStock Score: 45/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I begin with what the data actually gives me. BlackRock Health Sciences Term Trust common shares closed at $16.18 on 2026-10-13, with a market capitalization of $892.5 million. FairStock's calculated P/E is 4.77, and the stated dividend yield is 8.16%. On the surface, that is a low headline multiple and a high income stream. But Graham would immediately ask whether those earnings are recurring and whether the distribution is covered. Here, the evidence is thin. FairStock has only 0 years of filed results, so it cannot assign a Lynch category and notes that 3 years are needed. P/B, ROE, ROCE, D/E, revenue growth, profit growth, and beta are all unavailable. A P/E of 4.77 can signal deep value, or it can reflect a one-time accounting result in a trust whose portfolio I cannot inspect from these figures. The FairStock Score of 45/100 suggests the overall picture is not compelling enough to offset that uncertainty. The 52-week range is $13.70 to $17.25; at $16.18, the shares are near the upper end, so there is no obvious margin of safety from recent price action. The 8.16% dividend yield is attractive only if sustainable. Without filed financials, I cannot judge the durability of the earnings or the safety of the payout. In Buffett terms, this is outside my circle of competence as presented. The low multiple is interesting, but a value investor needs more evidence before calling it a bargain.

In plain English: BlackRock Health Sciences Term Trust common shares trade like a stock and the name links it to health sciences. The figures show a high income distribution and a price that looks low compared with reported earnings, but there are no filed annual results and many key financial details are missing. That makes the business hard to judge, so the low price may or may not be a true bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer